Thromboangiitis obliterans

Circulation

Volumn 121, Issue 16, 2010, Pages 1858-1861

  Piazza, Gregory ^a   Creager, Mark A ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; PREDNISONE;

ADULT; BUERGER DISEASE; CASE REPORT; HUMAN; MALE; PRIORITY JOURNAL; REVIEW; SMOKING; SUBCUTANEOUS NODULE; THROMBOPHLEBITIS; THROMBOSIS; VASCULITIS;

ADULT; ANGIOGRAPHY; FEMALE; HUMANS; LEG; MALE; THROMBOANGIITIS OBLITERANS; TOBACCO USE CESSATION; TOBACCO USE DISORDER;

EID: 77951703288     PISSN: 00097322     EISSN: 15244539     Source Type: Journal    
DOI: 10.1161/CIRCULATIONAHA.110.942383     Document Type: Review

References (18)

1. Olin JW. Thromboangiitis obliterans (Buerger's disease). N Engl J Med. 2000; 343:864-869.
2. Iwai T, Inoue Y, Umeda M, Huang Y, Kurihara N, Koike M, Ishikawa I. Oral bacteria in the occluded arteries of patients with Buerger disease. J Vasc Surg. 2005;42: 107-115. (Pubitemid 40966083)
3. Adar R, Papa MZ, Halpern Z, Mozes M, Shoshan S, Sofer B, Zinger H, Dayan M, Mozes E. Cellular sensitivity to collagen in thromboangiitis obliterans. N Engl J Med. 1983;308:1113-1116. (Pubitemid 13135196)
4. Eichhorn J, Sima D, Lindschau C, Turowski A, Schmidt H, Schneider W, Haller H, Luft FC. Antiendothelial cell antibodies in throm-boangiitis obliterans. Am J Med Sci. 1998; 315:17-23. (Pubitemid 28047565)
5. Avcu F, Akar E, Demirkilic U, Yilmaz E, Akar N, Yalcin A. The role of prothrombotic mutations in patients with Buerger's disease. Thromb Res. 2000;100:143-147.
6. Maslowski L, McBane R, Alexewicz P, Wysokinski WE. Antiphospholipid antibodies in thromboangiitis obliterans. Vasc Med. 2002;7:259-264. (Pubitemid 36469488)
7. Bozkurt AK, Koksal C, Ercan M. The altered hemorheologic parameters in thromboan-giitis obliterans: a new insight. Clin Appl Thromb Hemost. 2004;10:45-50. (Pubitemid 38543716)
8. Ohta T, Ishioashi H, Hosaka M, Sugimoto I. Clinical and social consequences of Buerger disease. J Vasc Surg. 2004;39:176-180. (Pubitemid 38056169)
9. Cooper LT, Henderson SS, Ballman KV, Offord KP, Tse TS, Holmes DR, Hurt RD. A prospective, case-control study of tobacco dependence in thromboangiitis obliterans (Buerger's disease). Angiology. 2006;57: 73-78.
10. Sasajima T, Kubo Y, Inaba M, Goh K, Azuma N. Role of infrainguinal bypass in Buerger's disease: an eighteen-year experience. Eur J Vasc Endovasc Surg. 1997;13: 186-192. (Pubitemid 27196429)
11. Fiessinger JN, Schafer M. Trial of iloprost versus aspirin treatment for critical limb ischaemia of thromboangiitis obliterans: the TAO Study. Lancet. 1990;335:555-557. (Pubitemid 20089238)
12. Montori VM, Kavros SJ, Walsh EE, Rooke TW. Intermittent compression pump for non-healing wounds in patients with limb ischemia: the Mayo Clinic experience (1998-2000). Int Angiol. 2002;21:360-366.
13. Donas KP, Schulte S, Ktenidis K, Horsch S. The role of epidural spinal cord stimulation in the treatment of Buerger's disease. J Vasc Surg. 2005;41:830-836. (Pubitemid 40693806)
14. Isner JM, Baumgartner I, Rauh G, Schainfeld R, Blair R, Manor O, Razvi S, Symes JF. Treatment of thromboangiitis obliterans (Buerger's disease) by intramuscular gene transfer of vascular endothe-lial growth factor: preliminary clinical results. J Vasc Surg. 1998;28:964-973. (Pubitemid 28562700)
15. Saito S, Nishikawa K, Obata H, Goto F. Autologous bone marrow transplantation and hyperbaric oxygen therapy for patients with thromboangiitis obliterans. Angiology. 2007;58:429-434. (Pubitemid 47301051)
16. Matoba S, Tatsumi T, Murohara T, Imaizumi T, Katsuda Y, Ito M, Saito Y, Uemura S, Suzuki H, Fukumoto S, Yamamoto Y, Onodera R, Teramukai S, Fukushima M, Matsubara H. Long-term clinical outcome after intramuscular implantation of bone marrow mononuclear cells (Therapeutic Angiogenesis by Cell Transplantation [TACT] trial) in patients with chronic limb ischemia. Am Heart J. 2008;156:1010-1018.
17. Durdu S, Akar AR, Arat M, Sancak T, Eren NT, Ozyurda U. Autologous bone-marrow mononuclear cell implantation for patients with Rutherford grade II-III thromboangiitis obliterans. J Vasc Surg. 2006;44:732-739. (Pubitemid 44441783)
18. Miyamoto K, Nishigami K, Nagaya N, Akutsu K, Chiku M, Kamei M, Soma T, Miyata S, Higashi M, Tanaka R, Nakatani T, Nonogi H, Takeshita S. Unblinded pilot study of autologous transplantation of bone marrow mononuclear cells in patients with thromboangiitis obliterans. Circulation. 2006;114:2679-2684. (Pubitemid 44967352)